Group 1 - The Hang Seng Index will announce its semi-annual review results on August 22, 2025, affecting major indices such as the Hang Seng Index, the Hang Seng China Enterprises Index, and the Hang Seng Tech Index, with changes effective from September 8, 2025 [1] - Several brokerages, including UBS, Huatai Securities, and CICC, have released reports predicting adjustments to the Hang Seng Index and potential candidates for inclusion in the Hong Kong Stock Connect [1][2] - CICC highlights the significant size of passive funds tracking flagship indices, with ETF sizes for the Hang Seng Index, the Hang Seng China Enterprises Index, and the Hang Seng Tech Index being approximately $30.35 billion, $6.63 billion, and $26.12 billion respectively, indicating substantial potential fund flows due to component changes [1] Group 2 - CICC estimates that potential candidates for inclusion in the Hang Seng Index include Bank of Communications (03328), Pop Mart (09992), Yum China (09987), XPeng Motors (09868), Huazhu Group (01179), JD Logistics (02618), and Innovent Biologics (01801) [1][2] - UBS predicts that stocks likely to be included in the Hang Seng Index are WuXi AppTec (02268), Pop Mart, JD Logistics, Kingsoft (03888), and Bank of Communications, while Pop Mart is also expected to be included in the Hang Seng China Enterprises Index [2] Group 3 - Companies such as Cao Cao Travel (02643), InnoCare Pharma (09606), and Zhou Liu Fu (06168) are expected to be included in the Hong Kong Stock Connect, which connects Hong Kong-listed companies with mainland investors [3] - CICC estimates that 19 stocks meet the criteria for inclusion in the Hong Kong Stock Connect, including Cao Cao Travel, InnoCare Pharma, Zhou Liu Fu, and others [3][4] - UBS forecasts potential candidates for the Hong Kong Stock Connect based on the Hang Seng Composite Index predictions, including East Asia Bank, InnoCare Pharma-B, Blue Moon Group, and others [3] Group 4 - Huatai Securities also anticipates that 19 stocks may be included in the Hong Kong Stock Connect, with a list that includes Yunzhisheng, InnoCare Pharma-B, and others [4] - Historical data indicates that newly included stocks in the Hong Kong Stock Connect tend to outperform the market, while stocks removed from the index face significant capital outflows [4]